United Kingdom
# |
Name |
EBITDA |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 13.42 B
|
Dec. 31, 2023 | USD 129.77 | -1.69% |
|
United Kingdom |
|
2 |
USD 4.31 B
|
March 31, 2024 | USD 10.94 | 1.86% |
|
United Kingdom |
|
3 |
USD 93.28 M
|
June 30, 2024 | USD 17.38 | -3.70% |
|
United Kingdom |
|
4 |
USD 19.27 M
|
Dec. 31, 2023 | USD 5.68 | 0.09% |
|
United Kingdom |
|
5 |
USD 14.67 M
|
Sept. 30, 2024 | USD 0.36 | 3.24% |
|
United Kingdom |
|
6 |
USD 14.08 M
|
April 30, 2024 | USD 0.64 | 0.47% |
|
United Kingdom |
|
7 |
USD 13.59 M
|
June 30, 2024 | USD 39.06 | 2.49% |
|
United Kingdom |
|
8 |
USD 11.07 M
|
Dec. 30, 2023 | USD 72.03 | -1.91% |
|
United Kingdom |
|
9 |
USD 9.77 M
|
Dec. 31, 2023 | USD 0.31 | 0.09% |
|
United Kingdom |
|
10 |
USD 8.18 M
|
March 31, 2024 | USD 0.78 | -0.69% |
|
United Kingdom |
|
11 |
USD 446.00 K
|
Dec. 31, 2023 | USD 0.70 | -2.31% |
|
United Kingdom |
|
12 |
USD -15.75 K
|
March 31, 2024 | USD 1.03 | NA |
|
United Kingdom |
|
13 |
USD -658.42 K
|
Nov. 30, 2023 | USD 0.03 | 0.09% |
|
United Kingdom |
|
14 |
USD -1.16 M
|
June 30, 2024 | USD 0.10 | 0.09% |
|
United Kingdom |
|
15 |
USD -1.20 M
|
Dec. 31, 2023 | USD 0.05 | 0.09% |
|
United Kingdom |
|
16 |
USD -1.31 M
|
Dec. 31, 2023 | USD 0.13 | -2.30% |
|
United Kingdom |
|
17 |
USD -1.45 M
|
Dec. 31, 2023 | USD 0.05 | 1.50% |
|
United Kingdom |
|
18 |
USD -1.98 M
|
March 31, 2024 | USD 0.15 | 0.09% |
|
United Kingdom |
|
19 |
USD -2.13 M
|
Sept. 30, 2024 | USD 0.14 | 0.09% |
|
United Kingdom |
|
20 |
USD -2.29 M
|
Dec. 31, 2023 | USD 0.02 | 2.68% |
|
United Kingdom |
|
21 |
USD -2.34 M
|
Dec. 31, 2023 | USD 0.21 | 0.09% |
|
United Kingdom |
|
22 |
USD -2.45 M
|
Dec. 31, 2023 | USD 0.04 | -9.47% |
|
United Kingdom |
|
23 |
USD -2.60 M
|
March 31, 2024 | USD 0.11 | -6.40% |
|
United Kingdom |
|
24 |
USD -3.34 M
|
Dec. 31, 2023 | USD 0.49 | 0.09% |
|
United Kingdom |
|
25 |
USD -3.36 M
|
May 31, 2024 | USD 0.24 | -4.72% |
|
United Kingdom |
|
26 |
USD -3.44 M
|
June 30, 2024 | USD 0.19 | -3.04% |
|
United Kingdom |
|
27 |
USD -3.85 M
|
Dec. 31, 2023 | USD 0.04 | -14.59% |
|
United Kingdom |
|
28 |
USD -4.21 M
|
June 30, 2024 | USD 0.31 | 0.09% |
|
United Kingdom |
|
29 |
USD -5.62 M
|
Aug. 31, 2023 | USD 0.16 | -0.68% |
|
United Kingdom |
|
30 |
USD -5.75 M
|
June 30, 2024 | USD 0.27 | 2.36% |
|
United Kingdom |
|
31 |
USD -5.93 M
|
Dec. 31, 2023 | USD 0.06 | 1.92% |
|
United Kingdom |
|
32 |
USD -6.61 M
|
March 31, 2024 | USD 2.29 | -3.78% |
|
United Kingdom |
|
33 |
USD -7.30 M
|
Dec. 31, 2023 | USD 4.80 | 0.73% |
|
United Kingdom |
|
34 |
USD -7.88 M
|
Dec. 31, 2023 | USD 0.05 | -16.59% |
|
United Kingdom |
|
35 |
USD -8.13 M
|
Dec. 31, 2023 | USD 0.20 | 0.09% |
|
United Kingdom |
|
36 |
USD -8.46 M
|
Dec. 31, 2023 | USD 0.04 | 0.09% |
|
United Kingdom |
|
37 |
USD -8.82 M
|
April 30, 2024 | USD 0.11 | -4.08% |
|
United Kingdom |
|
38 |
USD -9.11 M
|
Dec. 31, 2023 | USD 4.18 | -2.79% |
|
United Kingdom |
|
39 |
USD -9.34 M
|
Dec. 31, 2023 | USD 15.26 | 0.09% |
|
United Kingdom |
|
40 |
USD -9.48 M
|
June 30, 2024 | USD 0.03 | -4.36% |
|
United Kingdom |
|
41 |
USD -9.54 M
|
Dec. 31, 2023 | USD 0.62 | -2.80% |
|
United Kingdom |
|
42 |
USD -10.50 M
|
Dec. 31, 2023 | USD 5.03 | -1.57% |
|
United Kingdom |
|
43 |
USD -10.67 M
|
Dec. 31, 2023 | USD 0.71 | 0.09% |
|
United Kingdom |
|
44 |
USD -12.01 M
|
Sept. 30, 2023 | USD 0.01 | -33.27% |
|
United Kingdom |
|
45 |
USD -12.18 M
|
Dec. 31, 2023 | USD 0.03 | -2.14% |
|
United Kingdom |
|
46 |
USD -24.78 M
|
Dec. 31, 2023 | USD 0.14 | 0.09% |
|
United Kingdom |
|
47 |
USD -26.06 M
|
Dec. 31, 2023 | USD 3.06 | -8.38% |
|
United Kingdom |
|
48 |
USD -26.34 M
|
Dec. 31, 2023 | USD 0.23 | 1.46% |
|
United Kingdom |
|
49 |
USD -36.76 M
|
Dec. 31, 2023 | USD 1.04 | 1.96% |
|
United Kingdom |
|
50 |
USD -38.91 M
|
June 30, 2024 | USD 0.09 | 2.54% |
|
United Kingdom |
The Biotechnology company in United Kingdom with the highest EBITDA is AstraZeneca PLC (LSE: AZN.L) at USD 13.42 B.
The Biotechnology company in United Kingdom with the lowest EBITDA is Oxford Biomedica plc (LSE: OXB.L) at USD -189.09 M.
The top 10 Biotechnology companies in United Kingdom by EBITDA are AstraZeneca PLC, Roivant Sciences Ltd., Genus plc, Science Group plc, Benchmark Holdings plc, SDI Group plc, Bioventix PLC, NIOX Group Plc, EKF Diagnostics Holdings plc and ECO Animal Health Group plc.
The bottom 10 Biotechnology companies in United Kingdom by EBITDA are Oxford Biomedica plc, Bicycle Therapeutics plc, Autolus Therapeutics plc, Oxford Nanopore Technologies plc, Barinthus Biotherapeutics plc, Silence Therapeutics plc, Verona Pharma plc, Immunocore Holdings plc, Allergy Therapeutics plc and NuCana plc.